Daewoong Pharmaceutical Co. Ltd.

This study is testing whether a smartphone app called 'WellCheck' can help people with Type 2 diabetes better control their condition. About 470 patients will use the app, with one group getting extra support from their doctor through it. The main goal is to see if using the app …

This study aims to see how well two diabetes medications, Envlo and Envlomet SR, control blood sugar in real-world medical practice. It will observe 15,000 adults with type 2 diabetes for 24 weeks to measure changes in their blood sugar levels and check for safety. Unlike a contr…

This study is observing patients with Type 2 diabetes who are prescribed the medication enavogliflozin in their regular doctor's office. It aims to see how well the drug helps with weight loss and controlling blood sugar over 24 weeks in a real-world setting. Researchers will col…

This final-stage study is testing whether adding a new drug (DWC202314) to an existing two-drug combination works better for lowering blood pressure. It involves about 192 adults whose high blood pressure is still not under control with their current medication. Participants are …